Fig. 1From: Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trialSPIRIT schedule of enrolment, interventions, and assessments. *Baseline variables: age, sex, comorbidity, American Society of Anesthesiologists score, ERCP indication, PEP risk factors, use of pancreatic duct stents. ^Primary outcome: post-ERCP pancreatitis. #Secondary outcomes: incidence of delayed PEP (> 24 h after ERCP), severity of PEP, other ERCP complications, hydration-related complications, length of hospital and intensive care unit stay, health-related quality of life, cost-effectiveness, and exocrine and endocrine pancreatic insufficiencyBack to article page